EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 11500A |
Device Problems
Degraded (1153); Fluid/Blood Leak (1250); Gradient Increase (1270); Difficult to Open or Close (2921); Patient Device Interaction Problem (4001)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/29/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
The device was not returned to edwards for evaluation as it remains implanted.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
Edwards received information a patient with a 23mm 11500a aortic valve implanted two (2) years, is being evaluated for valve-in-valve procedure due to degeneration with severe aortic stenosis and moderate regurgitation, leaflets severely thicken and mobility restricted.Per medical records, the patient was hospitalized approximately a year ago for bacteremia successfully treated with antibiotics, tee at that time showed no apparent endocarditis.
|
|
Manufacturer Narrative
|
Added information to h10.Per external ct imaging review: the submitted ct images support the presence of an aortic bioprosthesis with the suggestion of leaflet thickening but without evident calcification, and a possible diastolic commissural gap that could correlate with aortic regurgitation.The implications of the slightly off-round appearance of the bioprosthesis in short axis is uncertain.
|
|
Manufacturer Narrative
|
The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Tissue degeneration-related structural deterioration, either calcific or non-calcific, are common chronic failure modes for this type of bioprosthetic heart valve.Operational mechanical stress and biological factors are generally believed to be the major contributors to the non-calcific bioprosthetic tissue degeneration.Structural valve deterioration (svd) can, and typically does, lead to chronic central leaks over a period of time.Svd is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes may occur singularly or concomitantly.Degeneration-related structural deterioration is most commonly related to patient factors and is not usually an indication of a device malfunction.The most likely cause is patient factors, including hyperlipidemia (hld) and coronary artery disease (cad).
|
|
Search Alerts/Recalls
|
|
|